Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 1,487,000 | 1,643,000 | 1,536,000 | 1,375,000 | 1,777,000 |
| Cost of Goods | 1,214,000 | 1,233,000 | 1,168,000 | 1,174,000 | 1,345,000 |
| Gross Profit | 273,000 | 410,000 | 368,000 | 201,000 | 432,000 |
| Operating Expenses | 319,000 | 806,000 | 166,000 | 211,000 | 171,000 |
| Operating Income | -46,000 | -396,000 | 202,000 | -10,000 | 261,000 |
| Interest Expense | 55,000 | 48,000 | 42,000 | 41,000 | 41,000 |
| Other Income | 114,000 | 11,000 | 13,000 | -18,000 | 79,000 |
| Pre-tax Income | 13,000 | -433,000 | 173,000 | -69,000 | 299,000 |
| Income Tax | 1,000 | -57,000 | 28,000 | 28,000 | 59,000 |
| Net Income Continuous | 12,000 | -376,000 | 145,000 | -97,000 | 240,000 |
| Net Income | $12,000 | $-376,000 | $145,000 | $-97,000 | $240,000 |
| EPS Basic Total Ops | 0.08 | -2.52 | 0.97 | -0.57 | 1.54 |
| EPS Basic Continuous Ops | 0.08 | -2.52 | 0.97 | -0.57 | 1.54 |
| EPS Diluted Total Ops | 0.08 | -2.52 | 0.96 | -0.56 | 1.52 |
| EPS Diluted Continuous Ops | 0.08 | -2.52 | 0.96 | -0.56 | 1.52 |
| EBITDA(a) | $32,000 | $-316,000 | $283,000 | $66,000 | $335,000 |